
Cancer drug combo shows promise for patients resistant to standard treatments
Fox News
The drug combination venetoclax and palbociclib could help AML patients overcome treatment resistance, according to Oregon Health and Science University research.
"Unfortunately, almost everyone will eventually have drug resistance." Khloe Quill is a lifestyle production assistant with Fox News Digital. She and the lifestyle team cover a range of story topics including food and drink, travel, and health.
More than 20,000 Americans are diagnosed with AML each year, making it one of the most common types of leukemia, data show. It is also one of the most aggressive.
More Related News













